Production (Stage)
AEON Biopharma, Inc.
AEON
$0.534
-$0.015-2.73%
AMEX
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 80,253.85% | -97.58% | -84.40% | 120.92% | -69.79% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 18.90% | -14.01% | 217.85% | -38.62% | -11.65% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 674.91% | -32.94% | -41.01% | 60.89% | -59.85% |
|
|||||
Total Current Assets | 674.91% | -32.94% | -41.01% | 60.89% | -59.85% |
Net Property, Plant & Equipment | -4.86% | -5.05% | -4.86% | 233.86% | -14.98% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Assets | 339.18% | -21.53% | -30.17% | 89.12% | -55.70% |
|
|||||
Total Accounts Payable | -58.76% | 27.65% | 52.81% | -53.55% | 92.53% |
Total Accrued Expenses | -26.02% | 36.03% | -17.85% | 16.63% | -33.61% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 62.81% | -5.47% | -4.48% | -34.63% | -26.26% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -38.94% | 31.91% | 2.85% | -34.64% | 22.29% |
|
|||||
Total Current Liabilities | -38.94% | 31.91% | 2.85% | -34.64% | 22.29% |
Long-Term Debt | 13.95% | -22.95% | 14.13% | 161.29% | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -5.41% | -4.90% | -4.60% | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -56.03% | -47.43% | 3.40% | -95.18% | 22.83% |
Total Liabilities | -20.78% | -12.14% | 7.16% | -83.28% | 25.97% |
|
|||||
Common Stock & APIC | 2.02% | 0.36% | 0.51% | 1.61% | 3.14% |
Retained Earnings | 2.11% | 0.48% | -1.44% | 27.74% | -24.92% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 60.37% | 10.97% | -14.82% | 85.91% | -29.62% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 60.37% | 10.97% | -14.82% | 85.91% | -29.62% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 60.37% | 10.97% | -14.82% | 85.91% | -29.62% |
|